Amgen’s Biosimilars Business Dips As Key Contributors Face Fresh Competition

Company Remains Confident That Future Launches Will See It Meet Ambitious Targets

Amgen logo next to syringe
Amgen expects to launch another six biosimilars by the end of the decade. • Source: Shutterstock

More from Earnings

More from Business